Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort study Posted on July 8th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Outcomes of combined left bundle branch area pacing with atrioventricular nodal ablation in patients with atrial fibrillation and pulmonary diseaseNext: Inflammatory biomarkers as predictors of systemic vs isolated pocket infection in patients undergoing transvenous lead extraction
Outcomes of combined left bundle branch area pacing with atrioventricular nodal ablation in patients with atrial fibrillation and pulmonary disease Posted on July 8th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Biotronik receives CE mark for Amvia Sky and Edge devicesNext: Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort study
Biotronik receives CE mark for Amvia Sky and Edge devices Posted on July 1st, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’Next: Outcomes of combined left bundle branch area pacing with atrioventricular nodal ablation in patients with atrial fibrillation and pulmonary disease